Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)

Flora McErlane1, Roberto Carrasco2, Lianne Kearsley-Fleet2

  • 1Paediatric Rheumatology, Great North Children's Hospital, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK; Rheumatology, Institute Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Insights

Children with juvenile idiopathic arthritis (JIA) show reduced height growth over three years. Early presentation is linked to better height outcomes, highlighting the need for timely paediatric rheumatology care.

Area of Science:

  • Pediatric Rheumatology
  • Growth and Development
  • Child Health

Background:

  • Juvenile idiopathic arthritis (JIA) can impact a child's growth trajectory.
  • Understanding early vertical growth patterns is crucial for managing JIA.
  • The Childhood Arthritis Prospective Study (CAPS) provides valuable data on pediatric arthritis.

Purpose of the Study:

  • To investigate early vertical growth patterns in UK children with JIA.
  • To identify factors associated with poor growth in this cohort.
  • To analyze growth data from the CAPS inception cohort over a 3-year period.

Main Methods:

  • Analysis of height z-scores and height velocity over 3 years.
  • Utilized World Health Organisation growth standards for assessment.
  • Employed univariable and multivariable linear regressions to identify growth predictors.

Main Results:

  • A cohort of 568 children with JIA was analyzed.
  • Significant decrease in height z-score observed from baseline to 3 years (p ≤ 0.0001).
  • Growth restriction (change in height z-score ≤-0.5) affected 39% of patients; higher baseline height predicted poorer change.

Conclusions:

  • Children with JIA experience reduced height growth in the first three years of the disease.
  • Late presentation to pediatric rheumatology is associated with lower initial height.
  • Patients with the lowest baseline height z-scores showed the most improvement at 3 years, emphasizing the importance of early intervention.
Abstract

Related Concept Videos

Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.4K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.4K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
711
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K